| Q39106216 | A doxycycline inducible, adenoviral bone morphogenetic protein-2 gene delivery system to bone |
| Q26824560 | A systematic review of animal models for Staphylococcus aureus osteomyelitis |
| Q95643042 | A systematic review on current osteosynthesis-associated infection animal fracture models |
| Q41034516 | Adjunctive therapies in the treatment of osteomyelitis |
| Q38010727 | Administration of growth factors for bone regeneration |
| Q38065221 | Adult multipotent stromal cell technology for bone regeneration: a review |
| Q36752277 | Anabolic agents and the bone morphogenetic protein pathway |
| Q36040760 | Application of bone morphogenetic proteins in orthopaedic practice: their efficacy and side effects |
| Q37068890 | Available biological treatments for complex non-unions |
| Q42290729 | Bone Marrow Aspirate Concentrate in Combination With Intravenous Iloprost Increases Bone Healing in Patients With Avascular Necrosis of the Femoral Head: A Matched Pair Analysis |
| Q39905853 | Bone morphogenetic proteins and tissue engineering: future directions |
| Q37677093 | Bone morphogenetic proteins in open fractures: past, present, and future |
| Q37983112 | Cell-mediated and direct gene therapy for bone regeneration |
| Q92628591 | Current Trends in Viral Gene Therapy for Human Orthopaedic Regenerative Medicine |
| Q36013793 | Delivery of growth factors using gene therapy to enhance bone healing |
| Q33835146 | Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures. |
| Q45857795 | Effect of BMP-2 gene transfer on bone healing in sheep |
| Q45027512 | Effects of bone morphogenetic protein 2 gene therapy on new bone formation during mandibular distraction osteogenesis at rapid rate in rabbits. |
| Q38000390 | Gene delivery to bone |
| Q35117004 | Gene therapy for bone healing |
| Q36975928 | Gene therapy to enhance allograft incorporation after host tissue irradiation |
| Q37995448 | Growth factor delivery: how surface interactions modulate release in vitro and in vivo |
| Q50997599 | Mesenchymal stem cell-mediated gene delivery of bone morphogenetic protein-2 in an articular fracture model. |
| Q35900599 | Modeling Staphylococcus epidermidis-Induced Non-Unions: Subclinical and Clinical Evidence in Rats |
| Q33713231 | Orthopedic gene therapy in 2008. |
| Q41186883 | Osteonecrosis of the femoral head: treatment with ancillary growth factors |
| Q38129027 | Replacement, refinement, and reduction: necessity of standardization and computational models for long bone fracture repair in animals. |
| Q35235414 | Scaffold-based anti-infection strategies in bone repair |
| Q35144378 | Self-complementary AAV2.5-BMP2-coated femoral allografts mediated superior bone healing versus live autografts in mice with equivalent biomechanics to unfractured femur |
| Q36942951 | The effect of surface demineralization of cortical bone allograft on the properties of recombinant adeno-associated virus coatings. |
| Q37068910 | Use of bone morphogenetic proteins for treatment of non-unions and future perspectives |
| Q38231254 | Using genes to facilitate the endogenous repair and regeneration of orthopaedic tissues |